查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2143587

PGS試劑盒市場：全球市場預測，2026-2032年

PGS Kit Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，PGS 試劑盒市場將成長至 18.3 億美元，複合年成長率為 7.75%。

主要市場統計數據
基準年 2025 10.8億美元
預計年份：2026年 11.5億美元
預測年份 2032 18.3億美元
複合年成長率 (%) 7.75%

PGS試劑盒市場：執行摘要與策略背景

胚胎著床前遺傳學篩檢（PGS）目前通常被認為是胚胎胚胎著床前染色體異常檢測（PGT-A）這一更廣泛框架的一部分，並與體外受精聯合使用，用於在胚胎移植前評估胚胎的染色體數目。其臨床意義取決於生育年齡、不孕症診斷、胚胎數量、檢查室能力、監管要求以及遺傳諮詢的品質。雖然此檢測可以輔助胚胎選擇流程，但它並不能保證胚胎著床、活產或排除任何遺傳或發育異常，因此在決定領養前需要慎重考慮。

臨床實踐正朝著更有選擇性和基於證據的方向發展。

目前的趨勢正從廣泛、常規的應用轉向基於患者特徵、胚胎數量、臨床病史和當地證據的個別化應用。儘管胚胎培養、玻璃化冷凍、切片檢查技術、定序和檢查室品管系統的進步正在影響臨床實踐，但專家指南仍然強調知情同意和檢測的局限性。區分篩檢和診斷變得越來越重要，尤其是在結果呈現嵌合狀、不確定性或技術受限的情況下。

人工智慧不會取代遺傳學專業知識，但它正在改變胚胎學的工作流程。

人工智慧正被用於評估胚胎影像、解讀延時影像、最佳化工作流程、品質監控和資料整合。雖然這些工具可以提高一致性並幫助檢查室整理複雜訊息，但其臨床價值取決於代表性的訓練數據、外部檢驗、可解釋性、網路安全和管治。人工智慧的輸出結果應作為輔助決策的訊息，而非取代胚胎學家的判斷、遺傳諮詢、醫生的監督或在臨床適用情況下最終的診斷過程。

區域洞察：監管、基礎設施和准入至關重要

北美擁有先進的生殖健康基礎設施和強大的檢查室技術，但服務取得、保險覆蓋範圍以及各州和地區層級的法規各不相同。歐洲則受各國具體法規、倫理審查和歐盟資料保護要求的影響。亞太地區擁有高度發展的體外受精（IVF）中心，臨床能力也在迅速提升，但法規和費用方面有顯著差異。拉丁美洲的特點是服務取得不均、醫療資源集中於私部門以及監管體系尚在發展中。中東的生殖健康能力正在不斷增強，並擁有其獨特的法律、宗教和倫理框架。非洲的情況仍然高度複雜，許多地區的先進檢測能力有限，亟需建立轉診網路、提供訓練和品質保證。

集團分析：區域集團創造自身的管治與進入條件

東南亞國協的市場在臨床基礎設施、監管和跨境醫療保健方面差異顯著，因此統一檢測標準至關重要。金磚國家成員國涵蓋了從已開發到發展中的各種生殖健康體系，在基因檢測、資料管治和成本效益方面也存在差異。歐盟高度重視隱私、醫療設備和檢查室合規性，以及各國生殖相關立法的實施。雖然七國集團（G7）國家普遍擁有成熟的臨床和研究體系，但在保險報銷和倫理法規方面仍存在差異。海灣合作理事會（GCC）國家在各自獨特的文化法規環境下提供專業的生育服務。北約成員國的醫療保健或胚胎植入前遺傳學檢測（PGT）政策體系並不統一，但其通用的安全和技術背景凸顯了建構具有韌性的檢查室、保障醫療數據安全和建立可靠供應鏈的重要性。

國家概況：國家政策與臨床能力驅動應用

在澳洲和加拿大，成熟的生育服務系統與司法管轄區的法規和就醫途徑等因素結合。美國擁有龐大的檢查室和臨床能力，但保險覆蓋範圍分散，各州政策不盡相同。英國、法國、德國、義大利和西班牙在結構化的歐洲監管和倫理環境下運作，但在允許的適應症、保險報銷和服務組織結構方面存在國別差異。日本和韓國擁有先進的輔助生殖技術，但其應用受到政策、人口優先事項和保險報銷框架的影響。中國正在嚴格監管的系統下擴展其生殖健康基礎設施。印度擁有龐大且多元化的生育服務體系，並受不斷發展的國家標準的約束。巴西和墨西哥的私部門活動活躍，但各地就醫途徑有差異。俄羅斯輔助生殖技術的使用受到國家法規、臨床能力和不斷發展的醫療保健系統的影響。

領導者的策略重點：建立信任、品質和臨床效用。

產業領導者應建立嚴格的分析和臨床品管體系，涵蓋切片檢查、檢體處理、定序、結果解讀、報告和能力測試。他們也應明確傳達PGT-A是一種篩檢工具，有明顯的局限性，支持獨立的遺傳諮詢，並制定針對嵌合體、無結果和結果不一致情況的處理方案。投資重點應包括檢查室互通性、安全的資料架構、透明的AI檢驗、員工培訓以及上市後或真實世界證據的收集。與臨床醫生、患者團體、監管機構和倫理專家的合作有助於負責任地推廣應用，而推廣策略必須解決經濟負擔、區域差異和文化適宜性諮詢等問題。

調查方法：基於證據對PGS試劑盒現況的解釋。

本執行摘要では、提示された市場定義（PGSキット）を用い、現代のPGT-Aおよび生殖補助医療の文脈においてこれを解釈しています。本評価は、市場規模ではなく、臨床ワークフロー、技術、規制、インフラ、倫理、アクセス、および地域差を中心に構成されています。得られた知見を、臨床、運営、または投資に関する意思決定に活用する前に、現在の査読済みエビデンス、専門学会のガイドライン、各国の法規制、檢查室の認定要件、および製品固有の規制文書と照らし合わせて檢驗する必要があります。用語や許容される用途は管轄区域によって異なるため、現地の専門家による檢驗が不可欠です。

結論：負責任的整合決定了其長期意義。

PGS試劑盒在輔助生殖技術領域佔有技術先進但臨床應用又十分複雜的地位。其價值不在於檢測本身，而在於適當的患者篩選、檢驗的檢查室流程、準確的結果解讀、諮詢以及與整個體外受精（IVF）流程的整合。儘管地區和國家差異仍將影響其應用範圍和允許的使用，但人工智慧若能得到負責任的管理，可以改善工作流程。那些優先考慮實證醫學、透明度、品質、隱私和公平患者照護的領導者，最有能力建立永續的臨床實踐。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 PGS試劑盒市場：依產品分類

  • 消耗品
    • 成套工具
    • 試劑
  • 裝置
    • 桌面設備
    • 即時分析設備

第8章 PGS試劑盒市場：依技術分類

  • 微陣列比較基因組雜合
    • 安捷倫
    • 賽默飛世爾科技公司 CGH
  • 次世代定序
    • Illumina
    • 賽默飛世爾科技
  • 即時PCR
    • 應用生物系統
    • Rotor-Gene

第9章 PGS試劑盒市場：依通路分類

  • 直銷
    • 現場銷售
    • 線上銷售
  • 銷售代理
    • 國際銷售代理
    • 全國銷售代理

第10章：PGS試劑盒市場：依應用領域分類

  • 非整倍體檢測
  • 遺傳疾病的檢測
  • 結構重組的檢測

第11章 PGS 試劑盒市場：以最終用戶分類

  • 診斷檢查室
    • 醫院檢查室
    • 獨立檢測實驗室
  • 不孕症治療診所
    • 體外受精（IVF）中心
    • 婦產科診所
  • 醫院
    • 私立醫院
    • 公立醫院

第12章 PGS試劑盒市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 PGS試劑盒市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 PGS試劑盒市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Agilent Technologies, Inc.
  • Aspira Women's Health Inc
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Bioarray SL
  • BlueGnome Ltd
  • CooperSurgical Inc
  • Danaher Corporation
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Fairfax Genetics Inc
  • Fulgent Genetics Inc
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • MGI Tech Co Ltd
  • Myriad Genetics, Inc.
  • Natera Inc
  • Oxford Nanopore Technologies Ltd
  • PerkinElmer Inc
  • QIAGEN NV
  • Quest Diagnostics Incorporated
  • Reprogenetics LLC
  • Sophia Genetics SA
  • Takara Bio Inc
  • Thermo Fisher Scientific Inc.

第17章 主要專家

Product Code: MRR-9C4233EE7D6E

The PGS Kit Market is projected to grow by USD 1.83 billion at a CAGR of 7.75% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.08 billion
Estimated Year [2026] USD 1.15 billion
Forecast Year [2032] USD 1.83 billion
CAGR (%) 7.75%

PGS Kit Market: Executive Summary and Strategic Context

Preimplantation genetic screening (PGS), now more commonly described within the broader framework of preimplantation genetic testing for aneuploidy (PGT-A), is used alongside in vitro fertilization to assess chromosome number in embryos before transfer. Its clinical relevance is shaped by reproductive age, infertility diagnoses, embryo availability, laboratory capability, regulatory requirements, and the quality of genetic counseling. Adoption decisions require careful interpretation because testing can support embryo-selection workflows but does not guarantee implantation, live birth, or the absence of all genetic or developmental conditions.

Clinical Practice Is Shifting Toward More Selective, Evidence-Based Use

The landscape is moving from broad, routine application toward more individualized use based on patient characteristics, embryo cohort size, clinical history, and local evidence. Improvements in embryo culture, vitrification, biopsy procedures, sequencing, and laboratory quality systems are influencing practice, while professional guidance continues to emphasize informed consent and limitations. The distinction between screening and diagnosis is increasingly important, particularly when results are mosaic, inconclusive, or technically limited.

Artificial Intelligence Is Reshaping Embryology Workflows Without Replacing Genetic Expertise

Artificial intelligence is being applied to embryo image assessment, time-lapse interpretation, workflow prioritization, quality monitoring, and data integration. These tools may improve consistency and help laboratories organize complex information, but their clinical value depends on representative training data, external validation, explainability, cybersecurity, and governance. AI outputs should remain decision-support inputs rather than substitutes for embryologist judgment, genetic counseling, physician oversight, or confirmatory diagnostic pathways where clinically indicated.

Regional Insights: Regulation, Infrastructure, and Access Drive Differences

North America combines advanced reproductive-medicine infrastructure with strong laboratory specialization, but access, insurance coverage, and state or provincial rules vary. Europe is shaped by country-specific regulation, ethical review, and European Union data-protection expectations. Asia-Pacific includes highly developed IVF centers alongside rapidly expanding clinical capacity, with substantial differences in regulation and affordability. Latin America is characterized by uneven access, private-sector concentration, and evolving oversight. The Middle East shows growing reproductive-care capability alongside distinct legal, religious, and ethical frameworks. Africa remains highly heterogeneous, with limited advanced laboratory capacity in many settings and an important need for referral networks, training, and quality assurance.

Group Insights: Regional Blocs Create Distinct Governance and Access Conditions

ASEAN markets differ substantially in clinical infrastructure, regulation, and cross-border care, making harmonized laboratory standards valuable. BRICS members span advanced and developing reproductive-health systems, with varied approaches to genetic testing, data governance, and affordability. The European Union places strong emphasis on privacy, medical-device and laboratory compliance, and national implementation of reproductive legislation. G7 countries generally have mature clinical and research ecosystems, although reimbursement and ethical rules remain diverse. GCC countries are developing specialized fertility services within culturally specific regulatory environments. NATO members do not constitute a single healthcare or PGT policy system, but their shared security and technology context underscores the importance of resilient laboratories, secure health data, and trusted supply chains.

Country Insights: National Policy and Clinical Capacity Shape Adoption

Australia and Canada combine established fertility services with jurisdiction-specific regulation and access considerations. The United States has extensive laboratory and clinical capacity, alongside fragmented coverage and differing state policies. The United Kingdom, France, Germany, Italy, and Spain operate within structured European regulatory and ethical environments, with national differences in permitted indications, reimbursement, and service organization. Japan and South Korea have advanced assisted-reproduction capabilities, while policy, demographic priorities, and reimbursement frameworks influence use. China is expanding reproductive-health infrastructure under a closely regulated system. India has a large and diverse fertility-services ecosystem governed by evolving national standards. Brazil and Mexico show substantial private-sector activity but uneven access across regions. Russia's use of assisted reproductive technologies is shaped by national regulation, clinical capacity, and changing healthcare conditions.

Strategic Priorities for Leaders: Build Trust, Quality, and Clinical Utility

Industry leaders should establish rigorous analytical and clinical quality systems covering biopsy, sample handling, sequencing, interpretation, reporting, and proficiency testing. They should communicate clearly that PGT-A is a screening tool with defined limitations, support independent genetic counseling, and create protocols for mosaic, no-result, and discordant findings. Investment priorities should include laboratory interoperability, secure data architecture, transparent AI validation, staff training, and post-market or real-world evidence collection. Partnerships with clinicians, patient groups, regulators, and ethics experts can improve responsible adoption while access strategies should address affordability, geographic gaps, and culturally appropriate counseling.

Research Methodology: Evidence-Based Interpretation of the PGS Kit Landscape

This executive summary uses the supplied market definition-PGS Kit-and interprets it within the contemporary PGT-A and assisted-reproduction context. The assessment is organized around clinical workflow, technology, regulation, infrastructure, ethics, access, and regional variation rather than commercial sizing. Insights should be validated against current peer-reviewed evidence, professional-society guidance, national legislation, laboratory accreditation requirements, and product-specific regulatory documentation before being used for clinical, operational, or investment decisions. Because terminology and permitted use vary by jurisdiction, local expert review is essential.

Conclusion: Responsible Integration Will Determine Long-Term Relevance

PGS kits occupy a technically sophisticated but clinically nuanced position within assisted reproduction. Their value depends less on testing alone than on appropriate patient selection, validated laboratory processes, accurate interpretation, counseling, and integration with the full IVF pathway. Regional and national differences will continue to shape access and permitted use, while AI can improve workflow support if governed responsibly. Leaders that prioritize evidence, transparency, quality, privacy, and equitable patient care will be best positioned to develop sustainable clinical practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. PGS Kit Market, by Product

  • 7.1. Introduction
  • 7.2. Consumables
    • 7.2.1. Kits
    • 7.2.2. Reagents
  • 7.3. Instruments
    • 7.3.1. Benchtop Instruments
    • 7.3.2. Real-Time Instruments

8. PGS Kit Market, by Technology

  • 8.1. Introduction
  • 8.2. Array Comparative Genomic Hybridization
    • 8.2.1. Agilent
    • 8.2.2. Thermo Fisher CGH
  • 8.3. Next-Generation Sequencing
    • 8.3.1. Illumina
    • 8.3.2. Thermo Fisher
  • 8.4. Real-Time PCR
    • 8.4.1. Applied Biosystems
    • 8.4.2. Rotor-Gene

9. PGS Kit Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Direct Sales
    • 9.2.1. Field Sales
    • 9.2.2. Online Sales
  • 9.3. Distributors
    • 9.3.1. International Distributors
    • 9.3.2. National Distributors

10. PGS Kit Market, by Application

  • 10.1. Introduction
  • 10.2. Aneuploidy Detection
  • 10.3. Genetic Disorder Detection
  • 10.4. Structural Rearrangement Detection

11. PGS Kit Market, by End User

  • 11.1. Introduction
  • 11.2. Diagnostic Laboratories
    • 11.2.1. Hospital Labs
    • 11.2.2. Independent Labs
  • 11.3. Fertility Clinics
    • 11.3.1. IVF Centers
    • 11.3.2. OBGYN Clinics
  • 11.4. Hospitals
    • 11.4.1. Private Hospitals
    • 11.4.2. Public Hospitals

12. PGS Kit Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. PGS Kit Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. PGS Kit Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agilent Technologies, Inc.
  • 16.2. Aspira Women's Health Inc
  • 16.3. BGI Group
  • 16.4. Bio-Rad Laboratories, Inc.
  • 16.5. Bioarray SL
  • 16.6. BlueGnome Ltd
  • 16.7. CooperSurgical Inc
  • 16.8. Danaher Corporation
  • 16.9. Eurofins Scientific SE
  • 16.10. F. Hoffmann-La Roche AG
  • 16.11. Fairfax Genetics Inc
  • 16.12. Fulgent Genetics Inc
  • 16.13. GenScript Biotech Corporation
  • 16.14. Illumina, Inc.
  • 16.15. Invitae Corporation
  • 16.16. Laboratory Corporation of America Holdings
  • 16.17. MGI Tech Co Ltd
  • 16.18. Myriad Genetics, Inc.
  • 16.19. Natera Inc
  • 16.20. Oxford Nanopore Technologies Ltd
  • 16.21. PerkinElmer Inc
  • 16.22. QIAGEN NV
  • 16.23. Quest Diagnostics Incorporated
  • 16.24. Reprogenetics LLC
  • 16.25. Sophia Genetics SA
  • 16.26. Takara Bio Inc
  • 16.27. Thermo Fisher Scientific Inc.

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global PGS Kit Market, Years Considered for the Study
  • FIGURE 2. Global PGS Kit Market, Research Design
  • FIGURE 3. Global PGS Kit Market, Research Framework
  • FIGURE 4. Global PGS Kit Market, Data Triangulation
  • FIGURE 5. Global PGS Kit Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global PGS Kit Market Size, by Product, 2025 vs 2032 (%)
  • FIGURE 7. Global PGS Kit Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global PGS Kit Market Size, by Technology, 2025 vs 2032 (%)
  • FIGURE 9. Global PGS Kit Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global PGS Kit Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 11. Global PGS Kit Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global PGS Kit Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 13. Global PGS Kit Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global PGS Kit Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global PGS Kit Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global PGS Kit Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global PGS Kit Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global PGS Kit Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global PGS Kit Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global PGS Kit Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global PGS Kit Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global PGS Kit Market Segmentation & Coverage
  • TABLE 2. Global PGS Kit Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 4. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Reagents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Reagents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Reagents Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Benchtop Instruments Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Benchtop Instruments Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Benchtop Instruments Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Real-Time Instruments Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Real-Time Instruments Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Real-Time Instruments Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 23. Global Array Comparative Genomic Hybridization Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Array Comparative Genomic Hybridization Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Array Comparative Genomic Hybridization Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Agilent Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Agilent Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Agilent Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global Thermo Fisher CGH Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Thermo Fisher CGH Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Thermo Fisher CGH Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global Next-Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global Next-Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global Next-Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global Illumina Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 36. Global Illumina Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 37. Global Illumina Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 38. Global Thermo Fisher Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 39. Global Thermo Fisher Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 40. Global Thermo Fisher Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 41. Global Real-Time PCR Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Global Real-Time PCR Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 43. Global Real-Time PCR Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 44. Global Applied Biosystems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 45. Global Applied Biosystems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 46. Global Applied Biosystems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 47. Global Rotor-Gene Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 48. Global Rotor-Gene Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 49. Global Rotor-Gene Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 50. Global PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 51. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 52. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 53. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 54. Global Field Sales Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Global Field Sales Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 56. Global Field Sales Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 57. Global Online Sales Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 58. Global Online Sales Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 59. Global Online Sales Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 60. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 61. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 62. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 63. Global International Distributors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 64. Global International Distributors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 65. Global International Distributors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 66. Global National Distributors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 67. Global National Distributors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 68. Global National Distributors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 69. Global PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 70. Global Aneuploidy Detection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 71. Global Aneuploidy Detection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 72. Global Aneuploidy Detection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 73. Global Genetic Disorder Detection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 74. Global Genetic Disorder Detection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 75. Global Genetic Disorder Detection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 76. Global Structural Rearrangement Detection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 77. Global Structural Rearrangement Detection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 78. Global Structural Rearrangement Detection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 79. Global PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 80. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 81. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 82. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 83. Global Hospital Labs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 84. Global Hospital Labs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 85. Global Hospital Labs Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 86. Global Independent Labs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 87. Global Independent Labs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 88. Global Independent Labs Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 89. Global Fertility Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 90. Global Fertility Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 91. Global Fertility Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 92. Global IVF Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 93. Global IVF Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 94. Global IVF Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 95. Global OBGYN Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 96. Global OBGYN Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 97. Global OBGYN Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 98. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 99. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 100. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 101. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 102. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 103. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 104. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 105. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 106. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 107. Global PGS Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 108. Asia-Pacific PGS Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 109. Asia-Pacific PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 110. Asia-Pacific PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 111. Asia-Pacific PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 112. Asia-Pacific PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 113. Asia-Pacific PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 114. Asia-Pacific PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 115. Asia-Pacific PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 116. Asia-Pacific PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 117. Asia-Pacific PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 118. Asia-Pacific PGS Kit Market Size, by Distributors, 2017-2032 (USD Million)
  • TABLE 119. Asia-Pacific PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 120. Asia-Pacific PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 121. Asia-Pacific PGS Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 122. Asia-Pacific PGS Kit Market Size, by Fertility Clinics, 2017-2032 (USD Million)
  • TABLE 123. Asia-Pacific PGS Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 124. North America PGS Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 125. North America PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 126. North America PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 127. North America PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 128. North America PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 129. North America PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 130. North America PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 131. North America PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 132. North America PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 133. North America PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 134. North America PGS Kit Market Size, by Distributors, 2017-2032 (USD Million)
  • TABLE 135. North America PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 136. North America PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 137. North America PGS Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 138. North America PGS Kit Market Size, by Fertility Clinics, 2017-2032 (USD Million)
  • TABLE 139. North America PGS Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 140. Latin America PGS Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 141. Latin America PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 142. Latin America PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 143. Latin America PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 144. Latin America PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 145. Latin America PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 146. Latin America PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 147. Latin America PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 148. Latin America PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 149. Latin America PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 150. Latin America PGS Kit Market Size, by Distributors, 2017-2032 (USD Million)
  • TABLE 151. Latin America PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 152. Latin America PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 153. Latin America PGS Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 154. Latin America PGS Kit Market Size, by Fertility Clinics, 2017-2032 (USD Million)
  • TABLE 155. Latin America PGS Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 156. Europe PGS Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 157. Europe PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 158. Europe PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 159. Europe PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 160. Europe PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 161. Europe PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 162. Europe PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 163. Europe PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 164. Europe PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 165. Europe PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 166. Europe PGS Kit Market Size, by Distributors, 2017-2032 (USD Million)
  • TABLE 167. Europe PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 168. Europe PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 169. Europe PGS Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 170. Europe PGS Kit Market Size, by Fertility Clinics, 2017-2032 (USD Million)
  • TABLE 171. Europe PGS Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 172. Middle East PGS Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 173. Middle East PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 174. Middle East PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 175. Middle East PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 176. Middle East PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 177. Middle East PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 178. Middle East PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 179. Middle East PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 180. Middle East PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 181. Middle East PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 182. Middle East PGS Kit Market Size, by Distributors, 2017-2032 (USD Million)
  • TABLE 183. Middle East PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 184. Middle East PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 185. Middle East PGS Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 186. Middle East PGS Kit Market Size, by Fertility Clinics, 2017-2032 (USD Million)
  • TABLE 187. Middle East PGS Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 188. Africa PGS Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 189. Africa PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 190. Africa PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 191. Africa PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 192. Africa PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 193. Africa PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 194. Africa PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 195. Africa PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 196. Africa PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 197. Africa PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 198. Africa PGS Kit Market Size, by Distributors, 2017-2032 (USD Million)
  • TABLE 199. Africa PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 200. Africa PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 201. Africa PGS Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 202. Africa PGS Kit Market Size, by Fertility Clinics, 2017-2032 (USD Million)
  • TABLE 203. Africa PGS Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 204. Global PGS Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 205. ASEAN PGS Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 206. ASEAN PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 207. ASEAN PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 208. ASEAN PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 209. ASEAN PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 210. ASEAN PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 211. ASEAN PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 212. ASEAN PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 213. ASEAN PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 214. ASEAN PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 215. ASEAN PGS Kit Market Size, by Distributors, 2017-2032 (USD Million)
  • TABLE 216. ASEAN PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 217. ASEAN PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 218. ASEAN PGS Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 219. ASEAN PGS Kit Market Size, by Fertility Clinics, 2017-2032 (USD Million)
  • TABLE 220. ASEAN PGS Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 221. GCC PGS Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 222. GCC PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 223. GCC PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 224. GCC PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 225. GCC PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 226. GCC PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 227. GCC PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 228. GCC PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 229. GCC PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 230. GCC PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 231. GCC PGS Kit Market Size, by Distributors, 2017-2032 (USD Million)
  • TABLE 232. GCC PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 233. GCC PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 234. GCC PGS Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 235. GCC PGS Kit Market Size, by Fertility Clinics, 2017-2032 (USD Million)
  • TABLE 236. GCC PGS Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 237. European Union PGS Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 238. European Union PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 239. European Union PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 240. European Union PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 241. European Union PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 242. European Union PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 243. European Union PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 244. European Union PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 245. European Union PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 246. European Union PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 247. European Union PGS Kit Market Size, by Distributors, 2017-2032 (USD Million)
  • TABLE 248. European Union PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 249. European Union PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 250. European Union PGS Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 251. European Union PGS Kit Market Size, by Fertility Clinics, 2017-2032 (USD Million)
  • TABLE 252. European Union PGS Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 253. BRICS PGS Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 254. BRICS PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 255. BRICS PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 256. BRICS PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 257. BRICS PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 258. BRICS PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 259. BRICS PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 260. BRICS PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 261. BRICS PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 262. BRICS PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 263. BRICS PGS Kit Market Size, by Distributors, 2017-2032 (USD Million)
  • TABLE 264. BRICS PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 265. BRICS PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 266. BRICS PGS Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 267. BRICS PGS Kit Market Size, by Fertility Clinics, 2017-2032 (USD Million)
  • TABLE 268. BRICS PGS Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 269. G7 PGS Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 270. G7 PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 271. G7 PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 272. G7 PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 273. G7 PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 274. G7 PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 275. G7 PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 276. G7 PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 277. G7 PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 278. G7 PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 279. G7 PGS Kit Market Size, by Distributors, 2017-2032 (USD Million)
  • TABLE 280. G7 PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 281. G7 PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 282. G7 PGS Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 283. G7 PGS Kit Market Size, by Fertility Clinics, 2017-2032 (USD Million)
  • TABLE 284. G7 PGS Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 285. NATO PGS Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 286. NATO PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 287. NATO PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 288. NATO PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 289. NATO PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 290. NATO PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 291. NATO PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 292. NATO PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 293. NATO PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 294. NATO PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 295. NATO PGS Kit Market Size, by Distributors, 2017-2032 (USD Million)
  • TABLE 296. NATO PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 297. NATO PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 298. NATO PGS Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 299. NATO PGS Kit Market Size, by Fertility Clinics, 2017-2032 (USD Million)
  • TABLE 300. NATO PGS Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 301. Global PGS Kit Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 302. United States PGS Kit Market Size, 2017-2032 (USD Million)
  • TABLE 303. United States PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 304. United States PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 305. United States PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 306. United States PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 307. United States PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 308. United States PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 309. United States PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 310. United States PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 311. United States PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 312. United States PGS Kit Market Size, by Distributors, 2017-2032 (USD Million)
  • TABLE 313. United States PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 314. United States PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 315. United States PGS Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 316. United States PGS Kit Market Size, by Fertility Clinics, 2017-2032 (USD Million)
  • TABLE 317. United States PGS Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 318. Canada PGS Kit Market Size, 2017-2032 (USD Million)
  • TABLE 319. Canada PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 320. Canada PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 321. Canada PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 322. Canada PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 323. Canada PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 324. Canada PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 325. Canada PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 326. Canada PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 327. Canada PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 328. Canada PGS Kit Market Size, by Distributors, 2017-2032 (USD Million)
  • TABLE 329. Canada PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 330. Canada PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 331. Canada PGS Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 332. Canada PGS Kit Market Size, by Fertility Clinics, 2017-2032 (USD Million)
  • TABLE 333. Canada PGS Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 334. Mexico PGS Kit Market Size, 2017-2032 (USD Million)
  • TABLE 335. Mexico PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 336. Mexico PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 337. Mexico PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 338. Mexico PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 339. Mexico PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 340. Mexico PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 341. Mexico PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 342. Mexico PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 343. Mexico PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 344. Mexico PGS Kit Market Size, by Distributors, 2017-2032 (USD Million)
  • TABLE 345. Mexico PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 346. Mexico PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 347. Mexico PGS Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 348. Mexico PGS Kit Market Size, by Fertility Clinics, 2017-2032 (USD Million)
  • TABLE 349. Mexico PGS Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 350. Brazil PGS Kit Market Size, 2017-2032 (USD Million)
  • TABLE 351. Brazil PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 352. Brazil PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 353. Brazil PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 354. Brazil PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 355. Brazil PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 356. Brazil PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 357. Brazil PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 358. Brazil PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 359. Brazil PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 360. Brazil PGS Kit Market Size, by Distributors, 2017-2032 (USD Million)
  • TABLE 361. Brazil PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 362. Brazil PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 363. Brazil PGS Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 364. Brazil PGS Kit Market Size, by Fertility Clinics, 2017-2032 (USD Million)
  • TABLE 365. Brazil PGS Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 366. United Kingdom PGS Kit Market Size, 2017-2032 (USD Million)
  • TABLE 367. United Kingdom PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 368. United Kingdom PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 369. United Kingdom PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 370. United Kingdom PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 371. United Kingdom PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 372. United Kingdom PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 373. United Kingdom PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 374. United Kingdom PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 375. United Kingdom PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 376. United Kingdom PGS Kit Market Size, by Distributors, 2017-2032 (USD Million)
  • TABLE 377. United Kingdom PGS Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 378. United Kingdom PGS Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 379. United Kingdom PGS Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 380. United Kingdom PGS Kit Market Size, by Fertility Clinics, 2017-2032 (USD Million)
  • TABLE 381. United Kingdom PGS Kit Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 382. Germany PGS Kit Market Size, 2017-2032 (USD Million)
  • TABLE 383. Germany PGS Kit Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 384. Germany PGS Kit Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 385. Germany PGS Kit Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 386. Germany PGS Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 387. Germany PGS Kit Market Size, by Array Comparative Genomic Hybridization, 2017-2032 (USD Million)
  • TABLE 388. Germany PGS Kit Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 389. Germany PGS Kit Market Size, by Real-Time PCR, 2017-2032 (USD Million)
  • TABLE 390. Germany PGS Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 391. Germany PGS Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
  • TABLE 392. Germany PGS Kit Market Size, b